Thuluvath, Paul J.
University of Maryland, Baltimore · Mercy Medical Center
8 papers on CoChatORCID 0000-0002-4374-4507
Most cited papers
- Verified
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Younossi, Z. M., Ratziu, V., Loomba, R., Rinella, M., Anstee, Q. M., Goodman, Z., Bedossa, P., Geier, A., Beckebaum, S., Newsome, P. N., et al. (2019) · The Lancet
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 1,277
- Verified
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Qin, S., Chen, M., Cheng, A.-L., Kaseb, A. O., Kudo, M., Lee, H. C., Yopp, A. C., Zhou, J., Wang, L., Wen, X., et al. (2023) · The Lancet
Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers
Cited by 545
- Verified
Effects of belapectin, an inhibitor of galectin-3, in patients with nonalcoholic steatohepatitis with cirrhosis and portal hypertension
Chalasani, N., Abdelmalek, M. F., Garcia-Tsao, G., Vuppalanchi, R., Alkhouri, N., Rinella, M., Noureddin, M., Pyko, M., Shiffman, M., Sanyal, A., et al. (2020) · Gastroenterology
Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation
Cited by 358
- Verified
Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: A nationwide analysis†
Nguyen, G. C., Sam, J., & Thuluvath, P. J. (2008) · Hepatology
Drug-Induced Hepatotoxicity and ProtectionPoisoning and overdose treatments
Cited by 107
- Verified
Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography
Moff, S. L., Kamel, I. R., Eustace, J., Lawler, L. P., Kantsevoy, S., Kalloo, A. N., & Thuluvath, P. J. (2006) · Gastrointestinal Endoscopy
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 98
- Verified
Prolonged waiting times for liver transplantation in obese patients
Segev, D. L., Thompson, R. E., Locke, J. E., Simpkins, C. E., Thuluvath, P. J., Montgomery, R. A., & Maley, W. R. (2008) · Annals of Surgery
Organ Transplantation Techniques and OutcomesLiver Disease and Transplantation
Cited by 91
- Verified
Bariatric Surgery in NAFLD
Chauhan, M., Singh, K., & Thuluvath, P. J. (2022) · Digestive Diseases and Sciences
Bariatric Surgery and OutcomesLiver Disease Diagnosis and Treatment
Cited by 48
- Verified
Open‐label, clinical trial extension: Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis
Mayo, M. J., Vierling, J. M., Bowlus, C. L., Levy, C., Hirschfield, G. M., Neff, G. W., Galambos, M. R., Gordon, S. C., Borg, B. B., Harrison, S. A., et al. (2024) · Alimentary Pharmacology & Therapeutics
Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms
Cited by 39
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free